Abstract:This review article is intended to describe how oxidative stress regulates cardiovascular disease development and progression. Epigenetic mechanisms related to oxidative stress, as well as more reliable biomarkers of oxidative stress, are emerging over the last years as potentially useful tools to design therapeutic approaches aimed at modulating enhanced oxidative stress "in vivo", thereby mitigating the consequent atherosclerotic burden. As a paradigm, we describe the case of obesity, in which the intertwining among oxidative stress, due to caloric overload, chronic low-grade inflammation induced by adipose tissue dysfunction, and platelet activation represents a vicious cycle favoring the progression of atherothrombosis. Oxidative stress is a major player in the pathobiology of cardiovascular disease (CVD). Reactive oxygen species (ROS)- dependent signaling pathways prompt transcriptional and epigenetic dysregulation, inducing chronic low-grade inflammation, platelet activation and endothelial dysfunction. In addition, several oxidative biomarkers have been proposed with the potential to improve current understanding of the mechanisms underlying CVD. These include ROS-generating and/or quenching molecules, and ROS-modified compounds, such as F2-isoprostanes. There is also increasing evidence that noncoding micro- RNA (mi-RNA) are critically involved in post- transcriptional regulation of cell functions, including ROS generation, inflammation, regulation of cell proliferation, adipocyte differentiation, angiogenesis and apoptosis. These molecules have promising translational potential as both markers of disease and site of targeted interventions. Finally, oxidative stress is a critical target of several cardioprotective drugs and nutraceuticals, including antidiabetic agents, statins, renin-angiotensin system blockers, polyphenols and other antioxidants. Further understanding of ROS-generating mechanisms, their biological role as well as potential therapeutic implications would translate into consistent benefits for effective CV prevention.

Nutriepigenomics in Environmental-Associated Oxidative Stress

Oxidative Stress and Its Role in Cd-Induced Epigenetic Modifications: Use of Antioxidants as a Possible Preventive Strategy

Environmental Chemical Stressors As Epigenome Modifiers: a New Horizon in Assessment of Toxicological Effects

Gut Microbiome Interactions with Oxidative Stress: Mechanisms and Consequences for Health

The Emerging Role of GSNOR in Oxidative Stress Regulation

Emerging environmental stressors and oxidative pathways in marine organisms: Current knowledge on regulation mechanisms and functional effects

Inside the genome: understanding genetic influences on oxidative stress

Drug-metabolizing Enzymes and Oxidative Stress

Oxidative Stress, Plant Natural Antioxidants, and Obesity

The Impact of Nutrition and Environmental Epigenetics on Human Health and Disease

Oxidative stress: an overview of past research and future insights

Epigenetic signatures underlying inflammation: an interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition

Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach

Oxidative Stress and Hypertension

Crosstalk Between Oxidative Stress and Epigenetics: Unveiling New Biomarkers in Human Infertility

Ultra-processed diet, systemic oxidative stress, and breach of immunologic tolerance

The Interplay between Endogenous and Foodborne Pro-Oxidants and Antioxidants in Shaping Redox Homeostasis

RONS and Oxidative Stress: An Overview of Basic Concepts

Oxidative Stress: Harms and Benefits for Human Health

Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair

Using Redox Proteomics to Gain New Insights into Neurodegenerative Disease and Protein Modification